The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) by Biogen Idec Ma Inc since 2005.
The trader's CIK number is 714655.
At the time of the last reporting, Biogen Idec Ma Inc was the 10% Owner of Sunesis Pharmaceuticals Inc. (stock ticker symbol SNSS).
Also see all insider trading activities at Sunesis Pharmaceuticals Inc.
Insider Buying | Insider Sales | Option Exercises | |||||
---|---|---|---|---|---|---|---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
2005 | TGEN | 0 | $0 | 560,813 | $448,952 | 0 | $0 |
Insider Buying | Insider Sales | Option Exercises | |||||
---|---|---|---|---|---|---|---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
2005 | SNSS | 714,286 | $5,000,002 | 0 | $0 | 0 | $0 |
1. Armata Pharmaceuticals, Inc. (TGEN)
2. Sunesis Pharmaceuticals Inc (SNSS)
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|---|---|---|---|---|
2005-08-15 | TGEN | Sale | 14,200 | .71 | 10,067 |
2005-08-10 | TGEN | Sale | 25,000 | .73 | 18,375 |
2005-08-09 | TGEN | Sale | 25,453 | .76 | 19,318 |
2005-08-03 | TGEN | Sale | 26,200 | .77 | 20,278 |
2005-08-01 | TGEN | Sale | 33,000 | .78 | 25,740 |
2005-07-28 | TGEN | Sale | 36,500 | .81 | 29,565 |
2005-07-20 | TGEN | Sale | 17,000 | .81 | 13,719 |
2005-07-22 | TGEN | Sale | 35,098 | .79 | 27,832 |
2005-07-26 | TGEN | Sale | 73,500 | .83 | 61,225 |
2005-07-18 | TGEN | Sale | 74,632 | .80 | 59,854 |
2005-07-26 | TGEN | Sale | 73,500 | .83 | 61,225 |
2005-07-22 | TGEN | Sale | 35,098 | .79 | 27,832 |
2005-07-20 | TGEN | Sale | 17,000 | .81 | 13,719 |
2005-07-18 | TGEN | Sale | 49,632 | .81 | 39,953 |
2005-07-13 | TGEN | Sale | 25,000 | .81 | 20,250 |
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|---|---|---|---|---|
2005-09-27 | SNSS | Buy | 714,286 | 7.00 | 5,000,002 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Biogen Idec Ma Inc (10% Owner of Sunesis Pharmaceuticals Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.